GlassScriptPhysician profile
Deepak T Patel
NPI 1821038852
$11,380.57
in general payments reported to CMS, 2019-2025
59 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $1,539 · 2021: $1,706 · 2022: $2,937 · 2023: $1,597 · 2024: $1,416 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,097 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,097.33 |
| Education | $116.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,544.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $914.37 | 2020-2025 | Glassia, Hyqvia, Cuvitru |
| Insmed, INC. | $844.74 | 2020-2025 | Arikayce |
| Paratek Pharmaceuticals, INC. | $793.94 | 2020-2025 | Nuzyra |
| Regeneron Healthcare Solutions, INC. | $682.94 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $638.54 | 2019-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $544.41 | 2019-2025 | Fasenra |
| Actelion Pharmaceuticals US, INC. | $510.74 | 2020-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $461.66 | 2019-2025 | Ofev |
| Electromed, INC. | $382.73 | 2021-2025 | Smartvest |
| Genzyme Corporation | $380.69 | 2019-2025 | |
| Mylan Specialty L.P. | $370.33 | 2019-2023 | Yupelri |
| Novo Nordisk INC | $306.68 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $302.05 | 2021-2024 | Acthar |
| Lilly USA, LLC | $239.68 | 2020-2023 | Mounjaro, Trulicity |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $229.05 | 2019-2025 | Zerbaxa, Winrevair, Keytruda |
| Jazz Pharmaceuticals INC. | $157.95 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $151.71 | 2020-2022 | |
| Glaxosmithkline, LLC. | $137.67 | 2019-2025 | Nucala |
| Ani Pharmaceuticals, INC. | $137.42 | 2023-2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $111.04 | 2019 | |
| Advanced Respiratory, INC | $101.26 | 2020-2021 | |
| Verona Pharma, INC. | $100.54 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $99.96 | 2022-2025 | Sunosi |
| Baxter Healthcare | $93.31 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Alnylam Pharmaceuticals INC. | $90.27 | 2022-2025 | Onpattro |
| Pulmonx Corporation | $74.32 | 2024-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| United Therapeutics Corporation | $70.60 | 2022-2024 | Tyvaso |
| Genentech USA, INC. | $67.97 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $66.29 | 2019 | |
| Smith+Nephew, INC. | $65.51 | 2020-2023 | Grafix Pl |
| Abbvie INC. | $60.00 | 2019-2022 | |
| Inogen, INC. | $48.91 | 2024-2025 | |
| Shire North American Group INC | $45.74 | 2019 | |
| Radius Health, INC. | $40.59 | 2021-2024 | Tymlos |
| Kerecis Limited | $40.00 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $38.18 | 2020 | |
| Horizon Therapeutics Plc | $36.24 | 2020-2021 | |
| Veran Medical Technologies, INC. | $35.38 | 2020-2021 | |
| Ceribell, INC. | $34.52 | 2023 | Ceribell Rapid Response Eeg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.77 | 2019 | |
| Phadia US INC. | $24.61 | 2024 | Immunocap |
| Alexion Pharmaceuticals, INC. | $21.64 | 2024 | Ultomiris |
| Inspire Medical Systems, INC. | $21.13 | 2023 | Inspire |
| Lundbeck LLC | $20.92 | 2020 | |
| Philips North America LLC | $19.75 | 2023 | |
| Abbott Laboratories | $17.73 | 2019 | |
| Acera Surgical, INC. | $17.33 | 2024 | Restrata Wound Matrix |
| Gilead Sciences, INC. | $17.14 | 2021 | |
| Tactile Systems Technology INC | $17.10 | 2024 | Entre Plus, Flexitouch Plus |
| 3b Medical, INC. | $15.70 | 2023 | Luna |
| Teva Pharmaceuticals USA, INC. | $14.65 | 2022 | |
| Aimmune Therapeutics, INC. | $14.56 | 2025 | Vowst |
| Olympus America INC. | $14.41 | 2021 | |
| Coastal Medical Technologies LLC | $14.15 | 2024 | |
| Nabriva Therapeutics, Plc | $13.68 | 2020 | |
| Pfizer INC. | $12.96 | 2022 | |
| Circassia INC. | $11.86 | 2020 | |
| Melinta Therapeutics, LLC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.